Akoya BioSciences (AKYA)

• Market cap: $123M
• 1 day: -2.35%
• 5 days: 9.69%
• 1 month: 15.28%
• 3 months: -13.54%
• 6 months: 11.66%
• Year to date: -47.91%
• 1 year: -47.13%
• 5 years: -90.44%
• 10 years: -90.44%
• Sector: Industrials
• Industry: Laboratory Analytical Instruments

About: Akoya Biosciences Inc is a life sciences technology company. It is delivering spatial biology solutions focused on transforming discovery, clinical research and diagnostics. Its PhenoCycler (formerly CODEX) and PhenoImager (formerly Phenoptics) platforms, reagents, software, and services, It offer end-to-end solutions to perform tissue analysis and spatial phenotyping across the full continuum from discovery through translational and clinical research and diagnostics.

Employees: 330

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

100% more funds holding in top 10

Funds holding in top 10: 1 [Q2] → 2 (+1) [Q3]

13% more capital invested

Capital invested by funds: $29.2M [Q2] → $32.9M (+$3.66M) [Q3]

6% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 18

0% more funds holding

Funds holding: 59 [Q2] → 59 (+0) [Q3]

0% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 8

0.87% less ownership

Funds ownership: 25.3% [Q2] → 24.43% (-0.87%) [Q3]

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $3 20% upside
• Avg. target: $3.83 54% upside
• High target: $5 101% upside

3 analyst ratings

• positive: 2 67%
• neutral: 1 33%
• negative: 0 0%

Piper Sandler David Westenberg 69% 1-year accuracy 27 / 39 met price target	20% upside $3	Overweight Reiterated	19 Nov 2024
Craig-Hallum Bill Bonello 67% 1-year accuracy 4 / 6 met price target	101% upside $5	Hold Downgraded	15 Nov 2024
Canaccord Genuity Kyle Mikson 46% 1-year accuracy 12 / 26 met price target	41% upside $3.50	Buy Maintained	15 Nov 2024